Dr. Debu Tripathy

home / authors / dr-debu-tripathy

Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston.

Articles

Discussing the Mission of CURE With Our Former and New Editors-In-Chief

Discussing the Mission of CURE With Our Former and New Editors-In-Chief

Dr. Joshua K. Sabari;Dr. Debu Tripathy
March 12th 2025

Our longtime editor-in-chief offers advice to his successor while discussing the news and education CURE magazine provides for patients with cancer, families and caregivers.

Image of tripathy.

We Have Come a Long Way

Dr. Debu Tripathy
March 10th 2025

CURE magazine's outgoing editor-in-chief, Dr. Debu Tripathy, reflects on 18 years of advances in cancer care, the impact of AI and the evolving future of oncology treatment.

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.

Understanding the Distinction Between HER2-Low and HER2-Ultralow Breast Cancer

Dr. Debu Tripathy
February 17th 2025

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.

Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.

An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer

Dr. Debu Tripathy
February 12th 2025

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Latest Updated Articles

Illustration of cells.
Published: March 10th 2025 | Updated: March 15th 2025
Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma
Image of woman with blonde hair.
Published: March 12th 2025 | Updated: March 15th 2025
Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
Image of woman with brown hair.
Published: March 10th 2025 | Updated: March 15th 2025
Understanding the Best Practices Associated With CDK4/6 Therapy in Breast Cancer
Image of woman with blondish hair.
Published: December 30th 2024 | Updated: March 15th 2025
Empowering Patients With Cancer Through Clear Clinical Trial Communication
A PSA for Myeloproliferative Neoplasms
Published: January 22nd 2019 | Updated: March 15th 2025
A PSA for Myeloproliferative Neoplasms
Dr. Applebaum in an interview with CURE
Published: May 7th 2023 | Updated: March 15th 2025
‘Knowledge Is Exponential’ in the Rare Blood Cancer Space